Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation
Non-lymphoid tissues (NLTs) harbor a pool of adaptive immune cells with largely
unexplored phenotype and development. We used single-cell RNA-seq to characterize …
unexplored phenotype and development. We used single-cell RNA-seq to characterize …
The characteristic direction: a geometrical approach to identify differentially expressed genes
NR Clark, KS Hu, AS Feldmann, Y Kou, EY Chen… - BMC …, 2014 - Springer
Background Identifying differentially expressed genes (DEG) is a fundamental step in
studies that perform genome wide expression profiling. Typically, DEG are identified by …
studies that perform genome wide expression profiling. Typically, DEG are identified by …
Malignancy‐associated immune responses: Lessons from human inborn errors of immunity
A Aliyath, A Eni‐Olotu, N Donaldson, P Trivedi - Immunology, 2023 - Wiley Online Library
It is widely understood that cancer is a significant cause of morbidity and mortality
worldwide. Despite numerous available treatments, prognosis for many remains poor, thus …
worldwide. Despite numerous available treatments, prognosis for many remains poor, thus …
Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
STAT3 is constitutively activated in many cancers and regulates gene expression to promote
cancer cell survival, proliferation, invasion, and migration. In diffuse large B cell lymphoma …
cancer cell survival, proliferation, invasion, and migration. In diffuse large B cell lymphoma …
Hypothesis of opposite interplay between the canonical WNT/beta-catenin pathway and PPAR gamma in primary central nervous system lymphomas
A Vallée, Y Lecarpentier, JN Vallée - Current Issues in Molecular Biology, 2019 - mdpi.com
Primary central nervous system lymphomas (PCNSLs) are angiocentric neoplasia which
present dense monoclonal lymphocyte proliferation, and occur in brain parenchyma in 90 …
present dense monoclonal lymphocyte proliferation, and occur in brain parenchyma in 90 …
Novel thieno [2, 3-b] quinoline-procaine hybrid molecules: A new class of allosteric SHP-1 activators evolved from PTP1B inhibitors
L Xu, X Mu, M Liu, Z Wang, C Shen, Q Mu, B Feng… - Chinese Chemical …, 2023 - Elsevier
Small molecule activators could equally provide powerful tools as inhibitors do for
interrogating cellular signal transduction. However, targeted protein activation is chemically …
interrogating cellular signal transduction. However, targeted protein activation is chemically …
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma
Janus kinases (JAKs) classically signal by activating STAT transcription factors but can also
regulate gene expression by epigenetically phosphorylating histone H3 on tyrosine 41 …
regulate gene expression by epigenetically phosphorylating histone H3 on tyrosine 41 …
Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma
Background Gene profiling of diffuse large B cell lymphoma (DLBCL) has revealed broad
gene expression deregulation compared to normal B cells. While many studies have …
gene expression deregulation compared to normal B cells. While many studies have …
Transcriptome analysis of diffuse large b-cell lymphoma cells inducibly expressing MyD88 L265P mutation identifies upregulated CD44, LGALS3, NFKBIZ, and BATF …
M Turi, A Anilkumar Sithara, L Hofmanová… - International Journal of …, 2023 - mdpi.com
During innate immune responses, myeloid differentiation primary response 88 (MyD88)
functions as a critical signaling adaptor protein integrating stimuli from toll-like receptors …
functions as a critical signaling adaptor protein integrating stimuli from toll-like receptors …
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma, and front line
therapies have not improved overall outcomes since the advent of immunochemotherapy …
therapies have not improved overall outcomes since the advent of immunochemotherapy …